Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 2

1.

Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG).

Yeo W, Boyer M, Chung HC, Ong SY, Lim R, Zee B, Ma B, Lam KC, Mo FK, Ng EK, Ho R, Clarke S, Roh JK, Beale P, Rha SY, Jeung HC, Soo R, Goh BC, Chan AT; Cancer Therapeutics Research Group (CTRG).

Cancer Chemother Pharmacol. 2007 Feb;59(3):295-300. Epub 2006 Jun 17.

PMID:
16783579
2.

Irofulven (MGI Pharma).

Baekelandt M.

Curr Opin Investig Drugs. 2002 Oct;3(10):1517-26. Review.

PMID:
12431030

Supplemental Content

Write to the Help Desk